POSTED
AT 8:51 AM
BY marketing team

iQGG in the Australian Financial Review

Dr George Syrmalis, Group CEO and Chairman of The iQ Group Global, is featured in The Australian Financial Review today.

In the interview Dr Syrmalis discusses the evolution of biotech in China, outlines The Group’s plans to enter the Chinese market with the ground-breaking biosensor platform technology, and details the strategy behind The Group’s proposed redomicile to the US.

Read the article online at https://www.afr.com/news/world/asia/australian-biotech-seeks-us-help-to-tackle-diabetes-in-china-20181030-h17b85 or below: